Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

December 1, 2022; Volume 63,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Schmidt, Christopher J.

    1. First-in-Human Evaluation of <sup>18</sup>F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
      You have access
      First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
      Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia G. Van Buskirk, Madeline D. Jenkins, Jose A. Montero Santamaria, Kevin P. Maresca, Akihiro Takano, Jeih-San Liow, Thomas A. Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoë A. Hughes, Christopher J. Schmidt, Shawn D. Doran, Andrew Mannes, Paolo Zanotti-Fregonara, Maarten Ooms, Cheryl L. Morse, Sami S. Zoghbi, Christer Halldin, Victor W. Pike and Robert B. Innis
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1919-1924; DOI: https://doi.org/10.2967/jnumed.122.263838
  2. Schoder, Heiko

    1. You have access
      2022 SNMMI Highlights Lecture: Oncology and Therapy, Part 1
      Heiko Schöder
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 13N-18N;
  3. Schook, Lawrence B.

    1. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
      You have access
      Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
      Ali Pirasteh, Sarvesh Periyasamy, Jennifer Jean Meudt, Yongjun Liu, Laura M. Lee, Kyle M. Schachtschneider, Lawrence B. Schook, Ron C. Gaba, Lu Mao, Adnan Said, Alan Blair McMillan, Paul F. Laeseke and Dhanansayan Shanmuganayagam
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1956-1961; DOI: https://doi.org/10.2967/jnumed.121.263736
  4. Schoormans, Jasper

    1. <sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
      You have access
      89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
      Kang H. Zheng, Jeffrey Kroon, Jasper Schoormans, Oliver Gurney-Champion, Sybren L. Meijer, Suzanne S. Gisbertz, Maarten C.C.M. Hulshof, Danielle J. Vugts, Guus A.M.S. van Dongen, Bram F. Coolen, Hein J. Verberne, Aart J. Nederveen, Erik S.G. Stroes and Hanneke W.M. van Laarhoven
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1880-1886; DOI: https://doi.org/10.2967/jnumed.121.263330
  5. Schulz, Volkmar

    1. You have access
      Nanoparticle Diagnostics and Theranostics in the Clinic
      Roger M. Pallares, Felix M. Mottaghy, Volkmar Schulz, Fabian Kiessling and Twan Lammers
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1802-1808; DOI: https://doi.org/10.2967/jnumed.122.263895
  6. Schwamborn, Kristina

    1. Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      You have access
      Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      Markus Kroenke, Lilit Schweiger, Thomas Horn, Bernhard Haller, Kristina Schwamborn, Alexander Wurzer, Tobias Maurer, Hans-Jürgen Wester, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1809-1814; DOI: https://doi.org/10.2967/jnumed.121.263707
  7. Schweiger, Lilit

    1. Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      You have access
      Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      Markus Kroenke, Lilit Schweiger, Thomas Horn, Bernhard Haller, Kristina Schwamborn, Alexander Wurzer, Tobias Maurer, Hans-Jürgen Wester, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1809-1814; DOI: https://doi.org/10.2967/jnumed.121.263707
  8. Scott, Peter J.H.

    1. Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
      Open Access
      Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
      Allen F. Brooks, Wade P. Winton, Jenelle Stauff, Janna Arteaga, Bradford Henderson, Jeremy Niedbala, Peter J.H. Scott and Benjamin L. Viglianti
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1949-1955; DOI: https://doi.org/10.2967/jnumed.122.263864
  9. Sebag, Frederic

    1. <sup>18</sup>F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
      You have access
      18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
      Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1865-1870; DOI: https://doi.org/10.2967/jnumed.122.263984
  10. Shanmuganayagam, Dhanansayan

    1. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
      You have access
      Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
      Ali Pirasteh, Sarvesh Periyasamy, Jennifer Jean Meudt, Yongjun Liu, Laura M. Lee, Kyle M. Schachtschneider, Lawrence B. Schook, Ron C. Gaba, Lu Mao, Adnan Said, Alan Blair McMillan, Paul F. Laeseke and Dhanansayan Shanmuganayagam
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1956-1961; DOI: https://doi.org/10.2967/jnumed.121.263736
« Previous (Pages : 20 21 22 23 24 25 26 27 28 29 ... 31) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (12)
Journal of Nuclear Medicine
Vol. 63, Issue 12
December 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
  • Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire